Relate AccountsProduction v2.7.2 v2.7.2 2022-07-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is human health consultancy services. 2 October 2023 2 2 NI608036 2023-06-30 NI608036 2022-06-30 NI608036 2021-06-30 NI608036 2022-07-01 2023-06-30 NI608036 2021-07-01 2022-06-30 NI608036 uk-bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 NI608036 uk-curr:PoundSterling 2022-07-01 2023-06-30 NI608036 uk-bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 NI608036 uk-bus:FullAccounts 2022-07-01 2023-06-30 NI608036 uk-bus:Director1 2022-07-01 2023-06-30 NI608036 uk-bus:Director2 2022-07-01 2023-06-30 NI608036 uk-bus:RegisteredOffice 2022-07-01 2023-06-30 NI608036 uk-bus:Agent1 2022-07-01 2023-06-30 NI608036 uk-core:ShareCapital 2023-06-30 NI608036 uk-core:ShareCapital 2022-06-30 NI608036 uk-core:RetainedEarningsAccumulatedLosses 2023-06-30 NI608036 uk-core:RetainedEarningsAccumulatedLosses 2022-06-30 NI608036 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-06-30 NI608036 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2022-06-30 NI608036 uk-bus:FRS102 2022-07-01 2023-06-30 NI608036 uk-core:FurnitureFittingsToolsEquipment 2022-07-01 2023-06-30 NI608036 uk-core:CurrentFinancialInstruments 2023-06-30 NI608036 uk-core:CurrentFinancialInstruments 2022-06-30 NI608036 uk-core:WithinOneYear 2023-06-30 NI608036 uk-core:WithinOneYear 2022-06-30 NI608036 uk-core:WithinOneYear 2023-06-30 NI608036 uk-core:WithinOneYear 2022-06-30 NI608036 uk-core:EmployeeBenefits 2022-06-30 NI608036 uk-core:EmployeeBenefits 2022-07-01 2023-06-30 NI608036 uk-core:AcceleratedTaxDepreciationDeferredTax 2023-06-30 NI608036 uk-core:TaxLossesCarry-forwardsDeferredTax 2023-06-30 NI608036 uk-core:OtherDeferredTax 2023-06-30 NI608036 uk-core:RevaluationPropertyPlantEquipmentDeferredTax 2023-06-30 NI608036 uk-core:EmployeeBenefits 2023-06-30 NI608036 2022-07-01 2023-06-30 NI608036 uk-bus:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: NI608036
 
 
MADB MEDICAL LTD
 
Directors' Report and Unaudited Financial Statements
 
for the financial year ended 30 June 2023
MADB MEDICAL LTD
DIRECTORS AND OTHER INFORMATION

 
Directors Mrs. Deirdre McBride
Mr. Barry McBride
 
 
Company Registration Number NI608036
 
 
Registered Office Unit 4
Steeple Road Industrial Estate
Antrim
BT41 1AB
 
 
Accountants Muldoon & Co
16 Mount Charles
Belfast
BT7 1NZ
Northern Ireland



MADB MEDICAL LTD
DIRECTORS' REPORT
for the financial year ended 30 June 2023

 
The directors present their report and the unaudited financial statements for the financial year ended 30 June 2023.
 
Principal Activity
The principal activity of the company is human health consultancy services.
     
Results and Dividends
The (loss)/profit for the financial year after providing for depreciation and taxation amounted to £(16,734) (2022 - £7,028).
     
Directors
The directors who served during the financial year are as follows:
     
Mrs. Deirdre McBride
Mr. Barry McBride
   
There were no changes in shareholdings between 30 June 2023 and the date of signing the financial statements.
     
Statement of Directors' Responsibilities
     
The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
     
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:
- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
___________________________
Mrs. Deirdre McBride
Director
     
2 October 2023



MADB MEDICAL LTD
Company Registration Number: NI608036
BALANCE SHEET
as at 30 June 2023

2023 2022
Notes £ £
 
Fixed Assets
Tangible assets 4 385 481
───────── ─────────
 
Current Assets
Debtors 5 24,666 24,591
Cash and cash equivalents 100,859 120,593
───────── ─────────
125,525 145,184
───────── ─────────
Creditors: amounts falling due within one year 6 (6,098) (9,117)
───────── ─────────
Net Current Assets 119,427 136,067
───────── ─────────
Total Assets less Current Liabilities 119,812 136,548
 
Provisions for liabilities 8 2 -
───────── ─────────
Net Assets 119,814 136,548
═════════ ═════════
 
Capital and Reserves
Called up share capital 1,000 1,000
Retained earnings 118,814 135,548
───────── ─────────
Equity attributable to owners of the company 119,814 136,548
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account.
           
For the financial year ended 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Board and authorised for issue on 2 October 2023 and signed on its behalf by
           
________________________________          
Mrs. Deirdre McBride          
Director          
           



MADB MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 30 June 2023

   
1. General Information
 
MADB MEDICAL LTD is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI608036. The registered office of the company is Unit 4, Steeple Road Industrial Estate, Antrim, BT41 1AB. The nature of the company's operations and its principal activities are set out in the Directors' Report. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 30 June 2023 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Fixtures, fittings and equipment - 20% Reducing Balance
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Work in progress
Work in progress is reflected in the accounts at the expected revenue due for work carried out during the period that has not yet been invoiced.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including directors, during the financial year was 2, (2022 - 2).
 
  2023 2022
  Number Number
 
Employees 2 2
  ═════════ ═════════
       
4. Tangible assets
  Fixtures, Total
  fittings and  
  equipment  
  £ £
Cost
At 1 July 2022 1,794 1,794
  ───────── ─────────
 
At 30 June 2023 1,794 1,794
  ───────── ─────────
Depreciation
At 1 July 2022 1,313 1,313
Charge for the financial year 96 96
  ───────── ─────────
At 30 June 2023 1,409 1,409
  ───────── ─────────
Net book value
At 30 June 2023 385 385
  ═════════ ═════════
At 30 June 2022 481 481
  ═════════ ═════════
       
5. Debtors 2023 2022
  £ £
 
Trade debtors 16,716 16,641
Other debtors 7,950 7,950
  ───────── ─────────
  24,666 24,591
  ═════════ ═════════
       
6. Creditors 2023 2022
Amounts falling due within one year £ £
 
Bank overdrafts 1,308 406
Taxation  (Note 7) - 1,647
Directors' current accounts 3,662 4,808
Accruals 1,128 2,256
  ───────── ─────────
  6,098 9,117
  ═════════ ═════════
       
7. Taxation 2023 2022
  £ £
 
Creditors:
Corporation tax - 1,647
  ═════════ ═════════
         
8. Provisions for liabilities
 
The amounts provided for deferred taxation are analysed below:
 
  Capital Total Total
  allowances    
       
    2023 2022
  £ £ £
 
At financial year start - - -
Charged to profit and loss (2) (2) -
  ───────── ───────── ─────────
At financial year end (2) (2) -
  ═════════ ═════════ ═════════